Preferences and willingness for starting daily, on-demand, and long-acting injectable HIV pre-exposure prophylaxis among transfeminine persons in the US, 2022–2023Duygu İşlek, Vani Vannappagari, Joanna A. Caldwell et al.|PLoS ONE|2025Cited by 3
Characteristics Associated With the HIV Preexposure Prophylaxis Care Continuum Among Transfeminine Persons in the United StatesDuygu İşlek, Vani Vannappagari, Travis Sanchez et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2025Cited by 0